Back

Inflammatory burden, but not genetic variation, predicts attenuated LDL cholesterol reduction after ST-elevation myocardial infarction

28 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Lipids, inflammation, and cardiometabolic risk Leukocytes, Inflammation, Immunity ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Ignas Simanauskas

Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas (Lithuania)

6 More presentations in this session

Presentation thumbnail
Investigating the heart-liver-axis in metabolic dysfunction-associated steatohepatitis and acute myocardial infarction
Mr A. Jacobs (Edinburgh, GB)
Abstract Slides
Presentation thumbnail
Tumor necrosis factor-α deficiency attenuates obesity and mitigates the severity of CpcPH-HFpEF in mouse models
Miss L. Zimmermann (Cologne, DE)
Abstract Slides
Presentation thumbnail
Circulating ectoenzyme CD38 is associated with diastolic dysfunction in subjects with metabolic syndrome: a population-based cross-sectional study
Doctor S. Ministrini (Zurich, CH)
Abstract Slides
Presentation thumbnail
Pro-inflammatory lipid profile in isolated adipocyte cultures from patients with congestive heart failure: a possible role in the development of cardiac cachexia.
Doctor A. Bongrani (Parma, IT)
Abstract Slides
Presentation thumbnail
Lp(a) impairs NK cell function potentially contributes to impaired immunity and increased cardiovascular disease risk
Doctor Y. Baumer (US)
Abstract Slides

Access the full session

Session thumbnail
Lipids, inflammation, and cardiometabolic risk

The Event

Event poster

ESC Congress 2026

28 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Drug related metabolites and genetic polymorphisms predict low low-density lipoprotein cholesterol response to atorvastatin treatment in patients with coronary heart disease
28 August 2020
thumbnail
Congress Presentation
Early inflammation and left ventricular remodeling after acute ST-elevation myocardial infarction: the Neutrophil-to-Lymphocyte Ratio as a predictor of cardiac dysfunction
21 March 2026
thumbnail
Congress Presentation
Standardized secondary lipid clinic improves cardiovascular outcomes following acute ST-segment elevated myocardial infarction (STEMI) in a single tertiary centre
24 April 2026
thumbnail
Congress Presentation
Two week interruption of statin therapy results in an exaggerated inflammatory phenotype in young myocardial infarction patients without standard modifiable risk factors
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources